Ameliorating replicative senescence of human bone marrow stromal cells by PSMB5 overexpression
Creators
- 1. Department of Anatomy, Shanxi Medical University, Taiyuan 030001 (China)
- 2. Department of Orthopaedics, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan 030001 (China)
- 3. Department of Anatomy, University of Hong Kong Faculty of Medicine, Hong Kong (Hong Kong)
- 4. Department of Medicine, University of Hong Kong Faculty of Medicine, Hong Kong (Hong Kong)
- 5. Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research - A*STAR (Singapore)
- 6. School of Biotechnology and Food Engineering, Hefei University of Technology, Hefei 230009 (China)
Description
Highlights: • PSMB5 overexpression restores the differentiation potential of aged hBMSCs. • PSMB5 overexpression enhances the proteasomal activity of late-stage hBMSCs. • PSMB5 overexpression inhibits replicative senescence and improved cell viability. • PSMB5 overexpression promotes cell growth by upregulating the Cyclin D1/CDK4 complex. - Abstract: Multipotent human bone marrow stromal cells (hBMSCs) potentially serve as a source for cell-based therapy in regenerative medicine. However, in vitro expansion was inescapably accompanied with cell senescence, characterized by inhibited proliferation and compromised pluripotency. We have previously demonstrated that this aging process is closely associated with reduced 20S proteasomal activity, with down-regulation of rate-limiting catalytic β-subunits particularly evident. In the present study, we confirmed that proteasomal activity directly contributes to senescence of hBMSCs, which could be reversed by overexpression of the β5-subunit (PSMB5). Knocking down PSMB5 led to decreased proteasomal activity concurrent with reduced cell proliferation in early-stage hBMSCs, which is similar to the senescent phenotype observed in late-stage cells. In contrast, overexpressing PSMB5 in late-stage cells efficiently restored the normal activity of 20S proteasomes and promoted cell growth, possibly via upregulating the Cyclin D1/CDK4 complex. Additionally, PSMB5 could enhance cell resistance to oxidative stress, as evidenced by the increased cell survival upon exposing senescent hBMSCs to hydrogen peroxide. Furthermore, PSMB5 overexpression retained the pluripotency of late-stage hBMSCs by facilitating their neural differentiation both in vitro and in vivo. Collectively, our work reveals a critical role of PSMB5 in 20S proteasome-mediated protection against replicative senescence, pointing to a possible strategy for maintaining the integrity of culture-expanded hBMSCs by manipulating the expression of PSMB5
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2013.12.113Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2013.12.113;
- PII
- S0006-291X(13)02184-0;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 443
- Journal Issue
- 4
- Journal Page Range
- p. 1182-1188
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46122134
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- AGING; BONE MARROW; CELL PROLIFERATION; COMPLEXES; DRUGS; HYDROGEN PEROXIDE; IN VITRO; IN VIVO; OXIDATION; PHENOTYPE; REGULATIONS; THERAPY; VIABILITY
- Descriptors DEC
- ANIMAL TISSUES; BODY; CHEMICAL REACTIONS; HEMATOPOIETIC SYSTEM; HYDROGEN COMPOUNDS; LAWS; MEDICINE; ORGANS; OXYGEN COMPOUNDS; PEROXIDES
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.